AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 30132426
Drug: SAM treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SAM treatment plus chlorine disinfectant
Trial: 30132426
Drug: SAM treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SAM treatment plus ceramic water filter
Trial: 30132426
Drug: Standard SAM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard SAM treatment
Trial: 20429742
Drug: Corset treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corset treatment (A)
Trial: 20429742
Drug: No corset
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No corset treatment (B)
Trial: 17267922
Drug: Drugs approved
RxNorm normalized name: glucose
DrugBank: Dextrose, unspecified form (DB09341)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Drugs approved by the EMEA for psychiatric disorders
Trial: 7863823
Drug: Short-term rhGH
RxNorm normalized name: hydrogen peroxide
DrugBank: Hydrogen peroxide (DB11091)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Short-term rhGH treatment (1 week)
Trial: 25201887
Drug: Low-dose fish
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose fish oil (3 capsules/day, 1080 mg eicosapentaenoic acid + docosahexaenoic acid)
Trial: 26283657
Drug: Low-dose fish
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose fish oil
Trial: 26283657
Drug: High-dose fish
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose fish oil
Trial: 17362279
Drug: Tramadol hydrochloride
RxNorm normalized name: Tramadol Hydrochloride
DrugBank: Tramadol (DB00193)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Tramadol hydrochloride 25 mg taken 1-2 hours before sexual activity for 8 weeks
Trial: 7075121
Drug: 1500 mg
RxNorm normalized name: inulin 1500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1500 mg of naproxen daily
Trial: 7075121
Drug: Naproxen (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naproxen (all doses)
Trial: 31582358
Drug: hIVIG (0.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: hIVIG (0.25 g/kg bodyweight, 500 mL infusion)
Trial: 28902127
Drug: Exercise therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exercise therapy (forced treadmill exercise)
Trial: 23708326
Drug: BCAA granules
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BCAA granules (Livact, 12 g/day) for 60 months
Trial: 20684955
Drug: Metformin 850
RxNorm normalized name: metFORMIN 850 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin 850 mg two times per day
Trial: 15001611
Drug: Phytoestrogens (114
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phytoestrogens (114 mg of isoflavonoids)
Trial: 9041098
Drug: Conjugated estrogen
RxNorm normalized name: Conjugated estrogen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conjugated estrogen (0.625 mg per day)
Trial: 9041098
Drug: Conjugated estrogen
RxNorm normalized name: Conjugated estrogen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conjugated estrogen + medroxyprogesterone acetate (2.5 mg daily)
Trial: 9041098
Drug: Transdermal estradiol
RxNorm normalized name: estradiol Transdermal System
DrugBank: Estradiol (DB00783)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal estradiol (0.1 mg per day)
Trial: 30431378
Drug: Conventional drug
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional drug treatment (vitamin E, orlistat, pioglitazone hydrochloride, atorvastatin, lisinopril, benzodiazepines, anti-inflammatory agents)
Trial: 27633647
Drug: Topical tacrolimus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical tacrolimus 0.1% cream
Trial: 8436146
Drug: Diclofenac 50
RxNorm normalized name: DICLOFENAC 50MG/MISOPROSTOL 200MCG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diclofenac 50 mg t.i.d.
Trial: 19699868
Drug: Eplerenone 25
RxNorm normalized name: eplerenone 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eplerenone 25 mg, titrated to 50 mg daily
Trial: 15566510
Drug: IFN 6
RxNorm normalized name: IFNγ
DrugBank: Interferon Gamma (DB15753)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IFN 6 million units (MU) monotherapy (N=30)
Trial: 15566510
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy with ribavirin and IFN 3 MU (N=30)
Trial: 9238624
Drug: PUFA supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PUFA supplementation (3.4 g daily for 12 months)
Trial: 29570536
Drug: Exercise training
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exercise training with low-dose testosterone (ExT)
Trial: 29570536
Drug: Exercise training
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exercise training (Ex) and Exercise training with low-dose testosterone (ExT)
Trial: 20581300
Drug: Preoperative chemotherapy
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Preoperative chemotherapy for high-grade osteosarcoma
Trial: 20581300
Drug: Postoperative chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Postoperative chemotherapy for low-grade or periosteal sarcomas with high-grade disease
Trial: 20581300
Drug: RT followed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RT followed by adjuvant chemotherapy for unresectable sarcomas
Trial: 20581300
Drug: Second-line therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Second-line therapy for relapsed or refractory disease
Trial: 20581300
Drug: Multiagent chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multiagent chemotherapy regimens for neoadjuvant and adjuvant treatment
Trial: 12444514
Drug: Intraarticular 20
RxNorm normalized name: dexamethasone
DrugBank: Dexamethasone acetate (DB14649)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intraarticular 20 mg of tenoxicam in 20 ml normal saline (Group T)
Trial: 7677678
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of symphysiofundal height and fetal abdominal circumference measurement
Trial: 7015492
Drug: 3% carbachol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3% carbachol ophthalmic solution
Trial: 17618750
Drug: Repeated courses
RxNorm normalized name: eicosyl povidone (2 eicosyl branches-repeat)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Repeated courses of antenatal steroids
Trial: 17618750
Drug: Single course
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single course of antenatal steroids
Trial: 19327618
Drug: AAV1/SERCA2a (intracoronary
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AAV1/SERCA2a (intracoronary infusion, doses ranging from 1.4 x 10(11) to 3 x 10(12) DNase resistant particles per patient)
Trial: 9141211
Drug: Syringe and
RxNorm normalized name: KIT, SYRINGE AND TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Syringe and needle administration of hepatitis B vaccine (Engerix‐B)
Trial: 30413829
Drug: Metformin monotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin monotherapy
Trial: 15881488
Drug: Sulfonylurea monotherapy
RxNorm normalized name: sulfanilylurea
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sulfonylurea monotherapy
Trial: 24089540
Drug: Metformin plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin plus sulfonylurea
Trial: 19548439
Drug: Traditional Chinese
RxNorm normalized name: BORNEOL 1 g in 6.5 g / MINT 1 g in 6.5 g / ANGELICA DAHURICA ROOT 0.5 g in 6.5 g TOPICAL POWDER [Traditional Chinese Medicine Health Card and TCM Epidemic Prevention Card]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Traditional Chinese medicine (TCM) combined with transcatheter arterial chemoembolization (TACE)
Trial: 18069097
Drug: RTS,S/AS02A vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RTS,S/AS02A vaccine
Trial: 8674803
Drug: Non-steroidal anti-inflammatory
RxNorm normalized name: Non-steroidal anti-inflammatory agent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-steroidal anti-inflammatory drugs (NSAIDs) for 2 weeks
Trial: 6524612
Drug: Prostaglandin-inhibitor naproxen
RxNorm normalized name: Naproxen
DrugBank: Naproxen (DB00788)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prostaglandin-inhibitor naproxen
Trial: 21847570
Drug: β-blocker propranolol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: β-blocker propranolol
Trial: 19172143
Drug: 0.75% ropivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.75% ropivacaine (1.5 mg/kg)
Trial: 19172143
Drug: 0.5% levobupivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5% levobupivacaine (1 mg/kg)
Trial: 12199319
Drug: Vitamin A
RxNorm normalized name: Vitamin A
DrugBank: Vitamin A (DB00162)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin A (25,000, 50,000, and 75,000 IU daily for one year)
Trial: 7597378
Drug: Linoleic acid
RxNorm normalized name: Linoleic acid
DrugBank: Linoleic acid (DB14104)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Linoleic acid preparation (placebo)
Trial: 1978947
Drug: 200 micrograms
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 micrograms budesonide daily
Trial: 1978947
Drug: 400 micrograms
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 micrograms budesonide daily
Trial: 8877232
Drug: No antibiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No antibiotic (control)
Trial: 17520441
Drug: Fast-dissolving lyophilized
RxNorm normalized name: melatonin
DrugBank: Melatonin (DB01065)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Fast-dissolving lyophilized tablet (LT)
Trial: 17520441
Drug: Immediate release
RxNorm normalized name: Namenda, immediate release oral kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate release tablet (IR)
Trial: 11915777
Drug: 3-day fasting
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3-day fasting with daily training activities
Trial: 31035054
Drug: Danhong injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Danhong injection (DHI)
Trial: 22819912
Drug: pegylated IFN‐α2a
FDA approved: no
EMA approved: no
PMDA approved: no
Description: pegylated IFN‐α2a (180 mcg/week) plus ribavirin (1000‐1200 mg/day) and amantadine (200mg/day) for 48 weeks
Trial: 17377767
Drug: Surfactant administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surfactant administration (n=8)
Trial: 9468207
Drug: Sibrafiban (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sibrafiban (5 mg daily to 10 mg twice daily for 28 days)
Trial: 9468207
Drug: Sibrafiban (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sibrafiban (5 mg twice daily to 15 mg once daily for 28 days)
Trial: 9468207
Drug: Sibrafiban (various
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sibrafiban (various doses)
Trial: 9468207
Drug: Aspirin (for
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin (for 28 days)
Trial: 7892866
Drug: Antenatal steroids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antenatal steroids
Trial: 7892866
Drug: Cesarean section
RxNorm normalized name: gonorrheal urethral secretion human
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cesarean section delivery with antenatal steroids
Trial: 22317851
Drug: Infiltration of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Infiltration of lidocaine plus 40 mg methylprednisolone acetate
Trial: 19875309
Drug: Discontinuation of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Discontinuation of ramipril 24 hours before surgery (Group A)
Trial: 17828093
Drug: Gel Metrogil
RxNorm normalized name: metronidazole Topical Gel [MetroGel]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gel Metrogil Denta and toothpaste Mexidol Dent aktiv
Trial: 7856526
Drug: gemfibrozil (1,200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: gemfibrozil (1,200 mg/day)
Trial: 21868369
Drug: Intravenous immunoglobulin
RxNorm normalized name: Intravenous immunoglobulin (IVIg)
DrugBank: Human immunoglobulin G (DB00028)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous immunoglobulin
Trial: 2228058
Drug: Centperazine (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Centperazine (300 mg/day)
Trial: 375449
Drug: Reserpine and
RxNorm normalized name: reserpine and diuretics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reserpine and kanamycin treatment
Trial: 31205182
Drug: Operative treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Operative treatment (Op)
Trial: 31205182
Drug: Nonoperative treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonoperative treatment (NonOp)
Trial: 28133925
Drug: Abatacept (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Abatacept (10 mg/kg intravenously on days 1, 15, 29, and week 8)
Trial: 23989945
Drug: Hospital treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hospital treatment
Trial: 21196806
Drug: Day hospital
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Day hospital treatment
Trial: 17616536
Drug: Fludrocortisone acetate
RxNorm normalized name: Fludrocortisone Acetate
DrugBank: Fludrocortisone (DB00687)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fludrocortisone acetate (FCA) 0.1 mg/d
Trial: 15775731
Drug: Unopposed transdermal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Unopposed transdermal 17beta‐estradiol and MPA
Trial: 11334901
Drug: HRT (Hormone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HRT (Hormone Replacement Therapy)
Trial: 12066081
Drug: Granuflex improved
RxNorm normalized name: Improvest
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Granuflex improved formulation (Convatec, UK)
Trial: 23157935
Drug: DASH diet
RxNorm normalized name: phentermine hydrochloride Oral Capsule [T-Diet]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DASH diet (4.1 g [105 mEq] potassium/2,100 kcal/d)
Trial: 23157935
Drug: Control diet
RxNorm normalized name: phentermine hydrochloride Oral Capsule [T-Diet]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control diet (1.7 g [43 mEq] potassium/2,100 kcal/d)
Trial: 19032700
Drug: Structured psychoeducational
RxNorm normalized name: LIPID,STRUCTURED (FROM SUNFLOWER OIL)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Structured psychoeducational intervention (n = 38) consisting of monthly sessions for 9 months
Trial: 16409530
Drug: Tramadol 1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tramadol 1.5 mg/kg i.v. before induction of general anesthesia
Trial: 16409530
Drug: Ilioinguinal and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ilioinguinal and iliohypogastric nerve block with 0.5% bupivacaine (0.25 ml/kg) before skin incision
Trial: 14974267
Drug: New preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: New preparation for wound edge protection
Trial: 7978588
Drug: Oral midazolam
RxNorm normalized name: Midazolam
DrugBank: Midazolam (DB00683)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oral midazolam (0.5 mg/kg)
Trial: 10793878
Drug: E2 1
RxNorm normalized name: PGE2 10 MG Vaginal Insert
FDA approved: no
EMA approved: no
PMDA approved: no
Description: E2 1 mg/NETA 0.5 mg
Trial: 27287856
Drug: Erlotinib 85
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erlotinib 85 mg/m2 daily
Trial: 27287856
Drug: Etoposide 50
RxNorm normalized name: etoposide 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etoposide 50 mg/m2/day for 21 days
Trial: 20594372
Drug: Subsidized artemisinin-based
RxNorm normalized name: artemisinin
DrugBank: Artemisinin (DB13132)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subsidized artemisinin-based combination therapies (ACTs)
Trial: 18238985
Drug: Postoperative adjuvant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Postoperative adjuvant pelvic radiation therapy
Trial: 18238985
Drug: Conservative treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conservative treatment for childbearing
Trial: 12571693
Drug: Administration of
RxNorm normalized name: IV solutions used in parenteral administration of fluids, electrolytes and nutrients
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Administration of acetylsalicylic acid
Trial: 12571693
Drug: Administration of
RxNorm normalized name: IV solutions used in parenteral administration of fluids, electrolytes and nutrients
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Administration of angiotensin-converting enzyme inhibitors
Trial: 12571693
Drug: Administration of
RxNorm normalized name: IV solutions used in parenteral administration of fluids, electrolytes and nutrients
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Administration of thrombolytics
Trial: 10491502
Drug: Effidrate cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Effidrate cream (glycerol alkyl-ether) applied on one side of the face
Trial: 1671008
Drug: Propranolol-atropine infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol-atropine infusion
Trial: 30973204
Drug: Basal insulin-supported
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Basal insulin-supported oral antidiabetic drugs therapy (BOT)
Trial: 27453733
Drug: Oral antidiabetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral antidiabetic drugs (OADs)
Trial: 15159318
Drug: Controlled diet
RxNorm normalized name: phentermine hydrochloride Oral Capsule [T-Diet]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Controlled diet with 5 servings (750 g) of fruits and vegetables daily
Trial: 15159318
Drug: Controlled diet
RxNorm normalized name: phentermine hydrochloride Oral Capsule [T-Diet]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Controlled diet with 2 servings (300 g) of fruits and vegetables daily
Trial: 8528169
Drug: Melphalan (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Melphalan (200 mg/m2) and methylprednisolone (1.5 g x 5) for conditioning
Trial: 7321973
Drug: Hydroalcoholic preparation
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydroalcoholic preparation (Brondecon elixir)
Trial: 7321973
Drug: Alcohol-free preparation
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alcohol-free preparation (Nuelin syrup)
Trial: 7321973
Drug: Comparison of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comparison of both preparations
Trial: 31658542
Drug: Micro-negative pressure
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Micro-negative pressure treatment
Trial: 27925676
Drug: Carfilzomib at
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carfilzomib at doses ranging from 15 to 20/56 mg/m2, administered as an intravenous infusion on 2 consecutive days each week for 3 weeks (days 1, 2, 8, 9, 15, and 16).
Trial: 27925676
Drug: Carfilzomib at
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carfilzomib at 20/56 mg/m2 as a 30-minute infusion for monotherapy and combination therapy.
Trial: 24464530
Drug: Citalopram (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Citalopram (2 × 20 mg)
Trial: 19490626
Drug: Nicotine nasal
RxNorm normalized name: nicotine Nasal Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicotine nasal spray (NNS) used hourly (intervention group)
Trial: 19490626
Drug: Nicotine nasal
RxNorm normalized name: nicotine Nasal Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicotine nasal spray (NNS) used ad libitum (control group)
Trial: 15070877
Drug: Lidocaine vaginal
RxNorm normalized name: lidocaine Vaginal Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine vaginal gel
Trial: 9659024
Drug: Rate of
RxNorm normalized name: Citrate of Magnesia
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rate of injection and volume of local anaesthetic
Trial: 28234053
Drug: BI 671800
RxNorm normalized name: BI-671800
DrugBank: BI-671800 (DB12524)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BI 671800 200 mg twice daily with fluticasone propionate
Trial: 28234053
Drug: BI 671800
RxNorm normalized name: BI-671800
DrugBank: BI-671800 (DB12524)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BI 671800 400 mg A.M. with fluticasone propionate
Trial: 24010986
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group received a single buccal injection and a single palatal injection before extraction
Trial: 7768075
Drug: Halofantrine 4.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Halofantrine 4.5 gm 7‐day loading dose regimen
Trial: 2138683
Drug: B vitamins
RxNorm normalized name: B-50 Hi Potency B Vitamins
FDA approved: no
EMA approved: no
PMDA approved: no
Description: B vitamins plus 75 mg diclofenac
Trial: 2138683
Drug: 75 mg
RxNorm normalized name: talc 75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 75 mg diclofenac alone
Trial: 7459427
Drug: U.K. sales
FDA approved: no
EMA approved: no
PMDA approved: no
Description: U.K. sales tablet
Trial: 7459427
Drug: Two tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two tablet formulations
Trial: 6355931
Drug: Aqueous solution
RxNorm normalized name: Zephiran Chloride 1:750 Antiseptic Aqueous Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aqueous solution
Trial: 28041599
Drug: 200mg of
RxNorm normalized name: Oil of peppermint
DrugBank: Peppermint oil (DB11198)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200mg of fermented soy containing 10mg of equol and 25mg of resveratrol (1 tablet/day)
Trial: 23963546
Drug: Valsartan/amlodipine 80/5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valsartan/amlodipine 80/5 mg